KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine.

Stewart ML, Tamayo P, Wilson AJ, Wang S, Chang YM, Kim JW, Khabele D, Shamji AF, Schreiber SL
Cancer Res. 2015 75 (14): 2897-906

PMID: 25968887 · PMCID: PMC4506246 · DOI:10.1158/0008-5472.CAN-14-2860

MeSH Terms (17)

Animals Azacitidine Biomarkers, Tumor Cystadenocarcinoma, Serous Decitabine Drug Resistance, Neoplasm Female Genes, ras Humans Mice Mice, Nude Mice, Transgenic Mutation Ovarian Neoplasms Prognosis Tumor Cells, Cultured Xenograft Model Antitumor Assays

Connections (1)

This publication is referenced by other Labnodes entities: